Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancer

por Zoli, W, Ricotti, L, Susino, M Dal, Barzanti, F, Frassineti, G L, Folli, S, Tesei, A, Bacci, F, Amadori, D
Publicado 1999

Activity of endovesical gemcitabine in BCG-refractory bladder cancer patients: a translational study

por Gunelli, R, Bercovich, E, Nanni, O, Ballardini, M, Frassineti, G L, Giovannini, N, Fiori, M, Pasquini, E, Ulivi, P, Pappagallo, G L, Silvestrini, R, Zoli, W
Publicado 2007

Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a multicentric phase II study.

por Aschele, C., Guglielmi, A., Frassineti, G. L., Milandri, C., Amadori, D., Labianca, R., Vinci, M., Tixi, L., Caroti, C., Ciferri, E., Verdi, E., Rosso, R., Sobrero, A.
Publicado 1998

Role of biological markers in the clinical outcome of colon cancer

por Nanni, O, Volpi, A, Frassineti, G L, De Paola, F, Granato, A M, Dubini, A, Zoli, W, Scarpi, E, Turci, D, Oliverio, G, Gambi, A, Amadori, D
Publicado 2002

5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer

por Sobrero, A, Guglielmi, A, Cirillo, M, Recaldin, E, Frassineti, G L, Aschele, C, Ravaioli, A, Testore, P, Caroti, C, Gallo, L, Pessi, M A, Cortesi, E, Turci, D, Grossi, F, Labianca, R
Publicado 2001

A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients

por Laquente, Berta, Lopez-Martin, Jose, Richards, Donald, Illerhaus, Gerald, Chang, David Z., Kim, George, Stella, Philip, Richel, Dirk, Szcylik, Cezary, Cascinu, Stefano, Frassineti, G. L., Ciuleanu, Tudor, Hurt, Karla, Hynes, Scott, Lin, Ji, Lin, Aimee Bence, Von Hoff, Daniel, Calvo, Emiliano
Publicado 2017

Phase II study of capecitabine-based concomitant chemoradiation followed by durvalumab as a neoadjuvant strategy in locally advanced rectal cancer: the PANDORA trial

por Grassi, E., Zingaretti, C., Petracci, E., Corbelli, J., Papiani, G., Banchelli, I., Valli, I., Frassineti, G.L., Passardi, A., Di Bartolomeo, M., Pietrantonio, F., Gelsomino, F., Carandina, I., Banzi, M., Martella, L., Bonetti, A.V., Boccaccino, A., Molinari, C., Marisi, G., Ugolini, G., Nanni, O., Tamberi, S.
Publicado 2023

Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma

por Rapposelli, I.G., Shimose, S., Kumada, T., Okamura, S., Hiraoka, A., Di Costanzo, G.G., Marra, F., Tamburini, E., Forgione, A., Foschi, F.G., Silletta, M., Lonardi, S., Masi, G., Scartozzi, M., Nakano, M., Shibata, H., Kawata, K., Pellino, A., Vivaldi, C., Lai, E., Takata, A., Tajiri, K., Toyoda, H., Tortora, R., Campani, C., Viola, M.G., Piscaglia, F., Conti, F., Fulgenzi, C.A.M., Frassineti, G.L., Rizzato, M.D., Salani, F., Astara, G., Torimura, T., Atsukawa, M., Tada, T., Burgio, V., Rimini, M., Cascinu, S., Casadei-Gardini, A.
Publicado 2021